Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
about
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guidelineGenotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiencyAdrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndromeGlucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiencyHirsutism: diagnosis and treatmentManagement of adolescents with congenital adrenal hyperplasiaHigh frequency of copy number variations and sequence variants at CYP21A2 locus: implication for the genetic diagnosis of 21-hydroxylase deficiency.ACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma.Low-dose dexamethasone therapy from infancy of virilizing congenital adrenal hyperplasiaStructure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia.Neuroendocrine causes of amenorrhea--an update.Final adult height in children with congenital adrenal hyperplasia treated with growth hormoneMutation analysis of the CYP21A2 gene in the Iranian population.Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.Ashwagandha root in the treatment of non-classical adrenal hyperplasia.The changing role of the clinical laboratory in the investigation of polycystic ovarian syndromeA giant ovarian cyst in a neonate with classical 21-hydroxylase deficiency with very high testosterone levels demonstrating a high-dose hook effect.Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families.Complement component 4 copy number variation and CYP21A2 genotype associations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Nonclassic congenital adrenal hyperplasia misdiagnosed as Turner syndromeSperm retrieval and concomitant tumor resection in azoospermic men with congenital adrenal hyperplasia and bilateral testicular adrenal rest tumors: a case report.Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update.Classic and non-classic 21-hydroxylase deficiency can be discriminated from P450 oxidoreductase deficiency in Japanese infants by urinary steroid metabolites.Inadequate testosterone suppression after medical and subsequent surgical castration in a patient with prostate cancer.Disorders of pubertal development.The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.Great genotypic and phenotypic diversities associated with copy-number variations of complement C4 and RP-C4-CYP21-TNX (RCCX) modules: a comparison of Asian-Indian and European American populations.An update to 21-hydroxylase deficient congenital adrenal hyperplasia.Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia.Acne-associated syndromes: models for better understanding of acne pathogenesis.Clinical outcomes in the management of congenital adrenal hyperplasia.Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.Biochemical and genetic diagnosis of 21-hydroxylase deficiency.Effect of maternal PCOS and PCOS-like phenotype on the offspring's health.Genetic architecture of acne vulgaris.Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.In vitro functional studies of rare CYP21A2 mutations and establishment of an activity gradient for nonclassic mutations improve phenotype predictions in congenital adrenal hyperplasia.Basal 17-hydroxyprogesterone cannot accurately predict nonclassical congenital adrenal hyperplasia in children and adolescents.Association of HLA alleles and haplotypes with CYP21A2 gene p. V282L mutation in the Croatian population.Premature pubarche in Mediterranean girls: high prevalence of heterozygous CYP21 mutation carriers.
P2860
Q24614223-EEC16A2B-78CB-4C27-BAEC-F7F73D34FD3CQ24619813-CF80C89D-4470-45C7-8E5B-87DAB5B77570Q24652739-D0335C93-A7C6-4898-94D5-57D899CADBE0Q26821908-BF42E911-C028-462B-B7B3-6196EA2296D0Q27014813-F596138B-C41B-45E3-A4FF-894ED5D98797Q27025013-2FC0928A-69A0-4D0F-AFB6-C0BDBCF6934BQ33334349-DA94458E-B593-4E10-9928-E08A52AE401AQ33586715-6DE5BFBC-6831-45A5-90F8-3F067722F8E8Q33633351-6DB3F9C9-D15B-4C46-B774-3906903A2369Q34325047-63C88E90-F9B3-4B69-B4CE-D67FF0A8FE18Q35096850-CAEED735-CC52-4BDA-83D3-13DC019F86A4Q35504463-0A726BA4-D3DB-4B1B-9523-6CA52DB6C8FDQ35752173-B7B508D2-254E-4153-B9FF-EDCB63947BF7Q35829925-FD74BC49-5D3C-4701-8C22-5E4FD6E389EFQ35978053-94003969-0022-4509-BC84-85A40BF5F8A4Q36013372-B858FFCA-4481-4731-9504-C70FFDB6877FQ36282313-F9365FBF-AA9F-4831-AC1F-0EB1BB6E9D0CQ36316086-A0D3B3B4-D1A6-433B-BC05-B493A91CC2DDQ36385217-92E4AB8E-3FE2-4A09-9B77-729A19E7E544Q36406599-682E3827-80FE-4809-864B-08DD8098F69DQ36758957-318204D8-F438-4ABC-A7B9-CAF3141502C0Q36802281-B2B757C6-D74E-450A-811C-7476F3C24DC7Q36881651-C1AAE9ED-4A29-48AC-9F7D-570DBC6119ADQ37144656-1D8E7956-500C-4519-ADC9-D25A1D225E3FQ37210368-241183AD-EF96-493D-B4F4-A5FCFCCD79F3Q37242225-A4933D12-CA24-4CA8-AB5E-7F427E9E2E38Q37277776-9F322AF8-04D9-41AA-8D7C-758897324003Q37508836-68883093-2857-4ECB-98A3-5CDE0506316CQ37703731-C1427275-C452-471E-887F-B8E9088AC71CQ37825558-34D39EE6-4A18-42BF-A1E4-284F7C5D54F6Q37974156-C5FA0187-5020-40D2-8EBC-17FE3001647DQ38529981-817BFE15-1685-4EE8-91C6-6B1DD9585DA5Q38580103-93FE99F6-016D-4571-A60F-6B7B6C48A0F6Q38660078-B6FFC330-6E0E-4225-94DB-8E68ADCDF83AQ38736949-E3B7B617-AB90-46AA-B5A7-FC8C0EB02D00Q38743172-8EE9FB1E-B843-48AF-B2C4-C46808466A74Q39172010-36F2FEFA-882B-4D83-B793-948C408CD9E6Q39288957-31426D3F-6E79-4A5A-A1C6-488159491341Q39317345-F8ABFD90-C16D-4826-A539-27763D251913Q39911408-A9A79CDC-328E-4365-A1F7-115D2715F97A
P2860
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
@ast
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
@en
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
@nl
type
label
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
@ast
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
@en
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
@nl
prefLabel
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
@ast
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
@en
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
@nl
P356
P1476
Extensive clinical experience: nonclassical 21-hydroxylase deficiency.
@en
P2093
Maria I New
P304
P356
10.1210/JC.2006-1645
P407
P577
2006-08-15T00:00:00Z